Pharma: AbbVie swallows biotech company Apogee for $10.9 billion
—·5h
With the acquisition of Apogee Therapeutics, AbbVie is strengthening its immunology portfolio and focusing on new growth drivers.
Channelscurrencies, semiconductors, stocksCountriesgermany, europeCategoriesmergers-acquisitions
Open original source ↗Published
6/22/2026, 12:27:40 PM
Fetched
6/22/2026, 3:07:11 PM
Confidence
60 / 100
Relevance
44 / 100
Trust
—
Language
de